Efficacy About Pulmonary Fibrosis Expert View RA-ILD risk calculator Previous Next Previous Play Next Importance of MDD for managing CTD-ILD patients by Dr E. Volkmann 19/02/2024 | Author: Boehringer Ingelheim Document ID: EM-MY-100277 About Pulmonary Fibrosis Meet Kim: SSc-ILD Patient Journey Meet Daniel: RA-ILD Patient Journey Meet John: IPF Patient Journey A1-R101||A2-R101||How to recognize pulmonary fibrosis on HRCT scans (Rheum) A1-R101||A2-R101||Time is of the essence: Suspect fibrotic interstitial lung disease A1-R101||A2-R101||ILD in SSc & when to consider treatment by Dr. E. Volkmann A1-R101||A2-R101||Risk factors for Progressive RA-ILD by Dr. E. Volkmann A1-R101||A2-R101||Importance of MDD for managing CTD-ILD patients by Dr E. Volkmann The Importance of Prompt Treatment of IPF RELATED CONTENT Read more 3:57 A1-R101||A2-R101||Risk factors for Progressive RA-ILD by Dr. E. Volkmann Watch now Opens in new tab Read more PDF The Importance of Prompt Treatment of IPF Download Opens in new tab Home Inflammation Nintedanib About Pulmonary Fibrosis A1-R101||A2-R101||Importance of MDD for managing CTD-ILD patients by Dr E. Volkmann
Read more 3:57 A1-R101||A2-R101||Risk factors for Progressive RA-ILD by Dr. E. Volkmann Watch now Opens in new tab
